Equitable access to diagnostics

Equitable access to diagnostics is a critical pillar in strengthening global health systems, ensuring that accurate and timely disease detection is available to all populations regardless of geography, income, or healthcare infrastructure. This session examines the disparities in diagnostic availability and the systemic solutions required to close these gaps. At the Infectious Diseases Conference, experts will address how diagnostic equity directly influences outbreak control, treatment outcomes, and disease surveillance accuracy.

Access to diagnostic services remains uneven across regions, with low-resource settings often facing shortages of laboratory infrastructure, trained personnel, and advanced testing technologies. These limitations delay disease identification and contribute to increased transmission and mortality. Strengthening supply chains, decentralizing diagnostic services, and investing in point-of-care technologies are essential to reducing these inequalities.

Rather than focusing solely on technology availability, discussions extend to affordability, distribution networks, and regulatory frameworks that influence diagnostic accessibility. At the Infectious Diseases Conference, attention is directed toward scaling rapid testing platforms, improving laboratory networks, and fostering partnerships between public and private sectors. Expanding diagnostic reach also enhances early outbreak detection and supports more effective public health interventions.

From a health systems perspective, Diagnostic Equity Access refers to ensuring fair and timely access to diagnostic tools across all population groups, enabling accurate identification of infections and supporting informed clinical and epidemiological decision-making. This concept reinforces that equitable diagnostics are fundamental to both individual care and broader disease control strategies.